According to research report the global HIV diagnostics market is projected to reach USD 3.88 billion by 2021 from USD 2.35 billion in 2016, at a CAGR of 10.5 % from 2016 to 2021.
Globally, the HIV diagnostics market is witnessing medium growth due to factors such as growing prevalence of HIV/AIDS worldwide, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments & kits, and increasing government initiatives. On the other hand, high cost of NAT and lack of mandates for NAT in developing countries are the major factors restraining the growth of this market.
On the basis of product, the HIV diagnostics market is segmented into consumable (assay, kits, reagents, and other consumables), instruments, and software & services. The consumables segment is expected to grow at the highest CAGR during the forecast period. Increasing awareness about advanced treatment such as rapid test and advancements of PoC instruments are the factors driving the growth of this segment.
Sample of the report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=66008285
On the basis of test type, the HIV diagnostics market is classified into antibody tests, viral load tests, CD4 tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment is further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 & Group O diagnostic tests. The viral load tests segment is expected to grow at the highest CAGR during the forecast period due to increasing awareness about early detection of HIV and high accuracy of these tests.
On the basis of end user, the HIV diagnostics market is divided into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). The diagnostic laboratories segment is expected to grow at the highest CAGR during the forecast period. Increasing awareness about HIV/AIDS and advancements in PoC instruments and consumables are major drivers for this end-user segment.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=66008285
On the basis of region, North America is expected to account for the largest share of the HIV diagnostics market in 2016. However, in the coming five years, growth in the HIV diagnostics market is likely to be centered on Asia. The increasing prevalence and incidence rate of HIV/AIDS in Asia provides growth opportunities to players in the HIV diagnostics products market. Key players are focusing on strategies such as product launches, partnerships, agreements, collaborations, and expansions to strengthen their foothold in the HIV diagnostics market.
The HIV diagnostics market is consolidated in nature due to the presence of a few large players. The prominent players in the market include Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc. (U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.).
No comments:
Post a Comment